New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
08:15 EDTAGN, VRX, NSRGYValeant says 'very confident' in meeting expectations for Q2, FY14
Valeant (VRX) says it will adjust its guidance on its Q2 earnings call to reflect the divestiture to Nestle (NSRGY) and its outlook for the rest of the year. Valeant says 13 of its top 15 products are growing overall and 9 of its top 15 products are growing by volume, refuting allegations made by Allergan (AGN). Comments from Valeant's "webcast to correct recent misrepresentations" related to its bid for Allergan.
News For VRX;AGN;NSRGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
09:18 EDTVRXValeant and Progenics' Relistor eceives positive opinion from EMA
Valeant (VRX) and Progenics (PGNX) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for Relistor Subcutaneous Injection for the treatment of opioid-induced constipation when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older. Additionally, the Committee has recommended a one-year extension of data/marketing protection for Relistor, to 11 years from the date of approval.
April 17, 2015
05:32 EDTNSRGYNestle confirms FY15 organic growth outlook of around 5%
Subscribe for More Information
05:29 EDTNSRGYNestle reports three-month organic growth of 4.4%, 1.9% real internal growth
Subscribe for More Information
April 16, 2015
11:44 EDTNSRGYNestle continues to streamline its business as competition heats up, WSJ says
Subscribe for More Information
April 14, 2015
06:51 EDTNSRGYNestle in advanced talks to sell Davigel unit to Brakes Group, Reuters reports
Nestle is in advanced discussions for the sale of its Davigel frozen food group to Bain Capital's Brakes Group, Reuters reports, citing a source. A second source says the sale of the deal, which is being handled by Credit Suisse, could raise EUR200M-EUR300M. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use